TIPAL: The effectiveness and risks of Treating people with Idiopathic Pulmonary fibrosis with the Addition of Lansoprazole, a randomised placebo-controlled multi-centre clinical trial


TIPAL is a mulitcentre clinical trial designed to find out if proton pump inhibitors (anti-acid drugs) are beneficial for people with idiopathic pulmonary fibrosis (a lung scarring condition) by assessing lung size, breathlessness scores and coughing. This remote study utilises electronic consent, televisits, home spirometry and wearable technology to support participants through the study in an efficient manner without them hardly needing to leave their home.

This study/project is funded by the NIHR Health Technology Assessment Programme (NIHR 127479). The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care.

TIPAL is registered on the ISRCTN Trial Registry: ISRCTN13526307 and ClinicalTrials.Gov

Twitter logo Follow the TIPAL trial on Twitter